COVID-19 Antibody Cocktail Sweetens Regeneron’s Growth Story

 
• By Joseph Haas
  
Coronavirus dollar bill
REGEN-COV revenue has driven sales for Regeneron, but it has underlying growth too
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business